Gastrointestinal health and restoration of microbiome
Dysbiosis or microbiome imbalance is increasingly recognised as a root cause for chronic inflammation diseases such as IBS, IBD, rheumatoid arthritis, alzheimer’s disease, Parkinson’s disease and others . Current solutions for treating chronic inflammatory diseases focus mainly on inactivating the immune system.
Dysbiosis leads to leaky gut and a total overload of the immune system. Different approaches help to enable the body to restore and sustain a healthy bacterial flora. Once restored, the body can take up the normal tasks and repair gradually the long term damage which has been caused.
During this webinar we will discuss the results of a study in which 135 patients with dysbiosis were involved. If you are looking to understand how dysbiosis can be better overcome register for this webinar now.
Presented by
Dr. Jef Verplaetse,
Managing Director
Jef holds a PhD in sciences (Biochemistry) of the University of Leuven (Belgium) and a MBA of the Vlerick Leuven Ghent Management School.
Dr. Jef Verplaetse has worked seven years as a sales director of Baxter International for their Belgian hospital division.
In 2008, Dr. Jef Verplaetse acquired, together with Philippe Houssiau, Laboratoria Smeets which specialises in manufacturing drugs in powder form. He is also fellow of the faculty of sciences of the KULeuven. He is board member of IWT the Flemish agency which supports R&D projects for local industry.
